Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo …

…, R Stienecker, J Suarez, N Tachikawa… - The lancet Respiratory …, 2021 - thelancet.com
Background Baricitinib is an oral selective Janus kinase 1/2 inhibitor with known anti-inflammatory
properties. This study evaluates the efficacy and safety of baricitinib in combination …

[PDF][PDF] Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants

…, A Kawana-Tachikawa, M Shinkai, N Tachikawa… - Immunity, 2021 - cell.com
Antibody titers against SARS-CoV-2 slowly wane over time. Here, we examined how time
affects antibody potency. To assess the impact of antibody maturation on durable neutralizing …

Homozygous CYP2B6* 6 (Q172H and K262R) correlates with high plasma efavirenz concentrations in HIV-1 patients treated with standard efavirenz-containing …

K Tsuchiya, H Gatanaga, N Tachikawa, K Teruya… - Biochemical and …, 2004 - Elsevier
Efavirenz (EFV) is metabolized by cytochrome P450 2B6 (CYP2B6) in the liver. We analyzed
the genotypes of CYP2B6 and their contribution to plasma EFV concentrations in 35 EFV-…

[HTML][HTML] DOCK2 is involved in the host genetics and biology of severe COVID-19

…, J Hamamoto, H Hayashi, Y Yoshimura, N Tachikawa… - Nature, 2022 - nature.com
Identifying the host genetic factors underlying severe COVID-19 is an emerging challenge 1
, 2 , 3 , 4 – 5 . Here we conducted a genome-wide association study (GWAS) involving 2,393 …

HLA-Cw8 primarily associated with hypersensitivity to nevirapine

…, J Tanuma, M Honda, I Genka, K Teruya, N Tachikawa… - Aids, 2007 - journals.lww.com
On examination he was afebrile. His pulse was 72 beats per minute and his blood pressure
was 170/100 mmHg. His jugular venous pressure was not raised. There was no oedema. …

Influence of human immunodeficiency virus type 1 infection on acute hepatitis A virus infection

S Ida, N Tachikawa, A Nakajima… - Clinical infectious …, 2002 - academic.oup.com
To assess the possible influence of human immunodeficiency virus type 1 (HIV-1) infection
on the clinical course of acute hepatitis A virus (HAV) infection, 15 HIV-1–infected …

Clinical and molecular characteristics of Klebsiella pneumoniae isolates causing bloodstream infections in Japan: occurrence of hypervirulent infections in health care

…, S Shiiki, K Hayakawa, N Tachikawa… - Journal of clinical …, 2019 - Am Soc Microbiol
Although hypervirulent Klebsiella pneumoniae (hvKp) has been associated with severe
community-acquired infections that occur among relatively healthy individuals, information about …

Urinary β 2-Microglobulin as a Possible Sensitive Marker for Renal Injury Caused by Tenofovir Disoproxil Fumarate

H Gatanaga, N Tachikawa, Y Kikuchi… - AIDS Research & …, 2006 - liebertpub.com
Tenofovir disoproxil fumarate (TDF) is renally excreted by a combination of glomerular filtration
and active tubular secretion, and its renal safety profiles have been reported based on a …

(1--> 3) beta-D-glucan as a quantitative serological marker for Pneumocystis carinii pneumonia

A Yasuoka, N Tachikawa, K Shimada… - Clinical Diagnostic …, 1996 - Am Soc Microbiol
We detected (1 --> 3) beta-D-glucan (beta-glucan), which is one of the major components of
the cyst wall of Pneumocystis carinii, in sera obtained from patients with P. carinii …

Association of HLA‐DRB1*09:01 with severe COVID‐19

…, Y Adachi, S Moriyama, K Terahara, N Tachikawa… - Hla, 2021 - Wiley Online Library
HLA‐A, ‐C, ‐B, and ‐DRB1 genotypes were analyzed in 178 Japanese COVID‐19 patients
to investigate the association of HLA with severe COVID‐19. Analysis of 32 common HLA …